within Pharmacolibrary.Drugs.ATC.D;

model D10AD01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.0009333333333333333,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.145,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008466666666666667,
    Tlag           = 600,            
    Vdp             = 0.952,
    k12             = 94,
    k21             = 94
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D10AD01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Tretinoin (all-trans retinoic acid) is a derivative of vitamin A. It is primarily used in topical form for the treatment of acne vulgaris and has been approved for this indication by regulatory agencies such as the FDA. Systemically, it is also used to induce remission in acute promyelocytic leukemia (APL).</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported for healthy adult volunteers (both sexes) after a single oral dose.</p><h4>References</h4><ol><li><p>Fitton, A, &amp; Goa, KL (1991). Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. <i>Drugs</i> 41(5) 780–798. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199141050-00007&quot;>10.2165/00003495-199141050-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1712709/&quot;>https://pubmed.ncbi.nlm.nih.gov/1712709</a></p></li><li><p>Schmitt-Hoffmann, AH, et al., &amp; Kovacs, P (2012). Oral alitretinoin: a review of the clinical pharmacokinetics and pharmacodynamics. <i>Expert review of clinical pharmacology</i> 5(4) 373–388. DOI:<a href=&quot;https://doi.org/10.1586/ecp.12.26&quot;>10.1586/ecp.12.26</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22943117/&quot;>https://pubmed.ncbi.nlm.nih.gov/22943117</a></p></li><li><p>Veraldi, S, et al., &amp; Barbareschi, M (2016). Are topical retinoids teratogenic?. <i>Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia</i> 151(6) 700–705. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27598619/&quot;>https://pubmed.ncbi.nlm.nih.gov/27598619</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D10AD01;
